About the Authors
- Cesar A. Gonzalez
-
* E-mail: cgonzalezd@ipn.mx
Affiliations Escuela Superior de Medicina, Instituto Politécnico Nacional, DF, México, EMGS/EMM/FAM, Universidad del Ejército, DF, México
- Jose A. Valencia
-
Affiliation Sección de Imagen Seccional-Unidad de Cuidados Intensivos, Hospital Central Militar, DF, México
- Alfredo Mora
-
Affiliation EMGS/EMM/FAM, Universidad del Ejército, DF, México
- Fernando Gonzalez
-
Affiliation EMGS/EMM/FAM, Universidad del Ejército, DF, México
- Beatriz Velasco
-
Affiliation EMGS/EMM/FAM, Universidad del Ejército, DF, México
- Martin A. Porras
-
Affiliation Sección de Imagen Seccional-Unidad de Cuidados Intensivos, Hospital Central Militar, DF, México
- Javier Salgado
-
Affiliation Sección de Imagen Seccional-Unidad de Cuidados Intensivos, Hospital Central Militar, DF, México
- Salvador M. Polo
-
Affiliation EMGS/EMM/FAM, Universidad del Ejército, DF, México
- Nidiyare Hevia-Montiel
-
Affiliation Departamento Ciencias de la Computación-IIMAS, Universidad Nacional Autónoma de México, DF, México
- Sergio Cordero
-
Affiliations Escuela Superior de Medicina, Instituto Politécnico Nacional, DF, México, Hospital General Balbuena, Secretaría de Salud del Distrito Federal, DF, México
- Boris Rubinsky
-
Affiliation Department of Mechanical Engineering, University of California, Berkeley, California, United States of America
Competing Interests
Cesar Gonzalez and Boris Rubinsky are the co-inventor of the following VEPS technology issued patents: "Volumetric induction phase shift detection system for determining tissue water content properties" United States (US) patent number 7,638,341 Dec 29, 2009; "Volumetric Induction phase shift system for determining tissue water content." US Patent 07910374, March 31 2011; "Volumetric induction phase shift detection system for determining tissue water content properties" US Patent number 8,101,421 January 24, 2012; "Volumetric induction phase shift detection system for determining tissue water content properties" US Patent number 8,361,391, January 29, 2013. These patents are assigned to the University of California (UC), Berkeley and were licensed to "Cerebrotech" a company in which Rubinsky, Gonzalez and UC Berkeley have a commercial interest through shares in that company. There are no further patents, products in development or marketed products to declare. The authors confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials. The study reported here was performed without any input, support and any involvement from Cerebrotech.
Author Contributions
Conceived and designed the experiments: CAG BR. Performed the experiments: JAV AM FG BV. Analyzed the data: CAG MAP JS SC BR. Contributed reagents/materials/analysis tools: MAP SMP JS NHM. Wrote the paper: CAG BR NHM.